Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 99.18 | 110.95 | 104.13 | 95.71 | 124.90 | 139.42 | 128.20 | 128.25 | 110.48 | 117.21 | 121.90 | 121.27 |
| Expenses | 77.76 | 88.36 | 87.80 | 74.69 | 107.67 | 106.25 | 99.65 | 104.14 | 102.96 | 111.49 | 105.49 | 104.76 |
| Operating Profit | 21.42 | 22.59 | 16.33 | 21.02 | 17.23 | 33.17 | 28.55 | 24.11 | 7.52 | 5.72 | 16.41 | 16.51 |
| OPM % | 21.60% | 20.36% | 15.68% | 21.96% | 13.80% | 23.79% | 22.27% | 18.80% | 6.81% | 4.88% | 13.46% | 13.61% |
| Other Income | 1.11 | 1.71 | 7.24 | 1.68 | 14.64 | 2.02 | 2.19 | -117.07 | 7.15 | -0.26 | 0.21 | 1.00 |
| Interest | 1.79 | 1.84 | 2.87 | 3.16 | 2.10 | 3.82 | 3.33 | 3.31 | 3.13 | 3.13 | 4.33 | 3.01 |
| Depreciation | 2.52 | 2.82 | 3.49 | 3.15 | 3.22 | 4.67 | 4.74 | 4.72 | 4.11 | 4.18 | 4.57 | 4.41 |
| Profit before tax | 18.22 | 19.64 | 17.21 | 16.39 | 26.55 | 26.70 | 22.67 | -100.99 | 7.43 | -1.85 | 7.72 | 10.09 |
| Tax % | 17.01% | 18.02% | 11.85% | 22.21% | 20.83% | 23.22% | 28.67% | -0.02% | -41.59% | -98.92% | 0.78% | 19.33% |
| Net Profit | 15.12 | 16.10 | 15.17 | 12.76 | 21.01 | 20.51 | 16.18 | -100.97 | 10.53 | -0.01 | 7.65 | 8.15 |
| EPS in Rs | 0.49 | 0.50 | 0.46 | 0.40 | 0.65 | 0.64 | 0.35 | -2.63 | 0.28 | 0.01 | 0.20 | 0.18 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 101 | 129 | 139 | 193 | 250 | 302 | 399 | 488 | 478 | 471 |
| Expenses | 89 | 103 | 114 | 154 | 197 | 243 | 322 | 388 | 424 | 425 |
| Operating Profit | 12 | 26 | 25 | 39 | 53 | 59 | 77 | 100 | 54 | 46 |
| OPM % | 12% | 20% | 18% | 20% | 21% | 19% | 19% | 20% | 11% | 10% |
| Other Income | 3 | 4 | 5 | 3 | 3 | 7 | 12 | 21 | -110 | 8 |
| Interest | 4 | 3 | 2 | 1 | 1 | 4 | 8 | 12 | 14 | 14 |
| Depreciation | 1 | 2 | 2 | 2 | 3 | 7 | 11 | 16 | 18 | 17 |
| Profit before tax | 10 | 25 | 25 | 38 | 52 | 54 | 70 | 92 | -88 | 23 |
| Tax % | 28% | 23% | 20% | 21% | 22% | 20% | 18% | 24% | -6% | |
| Net Profit | 7 | 19 | 20 | 30 | 40 | 44 | 57 | 70 | -83 | 26 |
| EPS in Rs | 2.25 | 6.19 | 2.65 | 3.94 | 1.30 | -0.00 | 1.74 | 1.82 | -2.14 | 0.67 |
| Dividend Payout % | 4% | 2% | 4% | -0% | 8% | 6% | 5% | -5% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 20% | 17% | -10% | ||
| Compounded Profit Growth | % | 1% | % | -71% | ||
| Stock Price CAGR | % | % | -10% | -26% | ||
| Return on Equity | % | 11% | 11% | 6% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 8 | 8 | 31 | 31 | 33 | 38 | 38 |
| Reserves | 23 | 42 | 57 | 87 | 197 | 238 | 397 | 563 | 484 |
| Borrowings | 30 | 25 | 30 | 21 | 35 | 68 | 151 | 142 | 162 |
| Other Liabilities | 16 | 21 | 14 | 18 | 24 | 37 | 113 | 103 | 157 |
| Total Liabilities | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 846 | 841 |
| Fixed Assets | 26 | 29 | 32 | 38 | 53 | 122 | 254 | 370 | 325 |
| CWIP | 1 | 2 | 3 | 4 | 10 | 35 | 97 | 9 | 31 |
| Investments | 0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 46 | 61 | 74 | 92 | 224 | 216 | 342 | 467 | 485 |
| Total Assets | 72 | 91 | 109 | 133 | 287 | 374 | 694 | 846 | 841 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 8 | 14 | 12 | 30 | 6 | 29 | 13 | 27 | -43 |
| Cash from Investing Activity | -4 | -6 | -7 | -11 | -63 | -92 | -161 | -93 | -5 |
| Cash from Financing Activity | -5 | -9 | 3 | -11 | 108 | 26 | 172 | 81 | 2 |
| Net Cash Flow | -1 | -0 | 8 | 7 | 51 | -37 | 24 | 15 | -46 |
| Free Cash Flow | 3 | 9 | 6 | 20 | -18 | -72 | -72 | -16 | -37 |
| CFO/OP | 88% | 75% | 69% | 94% | 33% | 71% | 29% | 41% | -61% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 77 | 70 | 72 | 68 | 88 | 97 | 137 | 137 | 171 |
| Inventory Days | 99 | 123 | 141 | 77 | 94 | 123 | 132 | 155 | 108 |
| Days Payable | 52 | 48 | 37 | 29 | 33 | 55 | 90 | 59 | 87 |
| Cash Conversion Cycle | 124 | 145 | 177 | 116 | 149 | 165 | 180 | 234 | 193 |
| Working Capital Days | 7 | 43 | 59 | 70 | 86 | 85 | 63 | 103 | 71 |
| ROCE % | 44% | 34% | 38% | 28% | 20% | 17% | 16% | 6% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 48.49% | 46.08% | 45.43% | 45.43% | 44.71% | 44.71% | 44.14% | 44.14% | 40.48% | 39.70% | 36.69% | 36.69% |
| FIIs | 0.95% | 1.76% | 2.06% | 1.55% | 1.58% | 0.16% | 0.08% | 2.89% | 3.10% | 3.33% | 1.31% | 1.25% |
| Public | 50.56% | 52.17% | 52.51% | 53.01% | 53.69% | 55.12% | 55.77% | 52.97% | 56.41% | 56.97% | 62.01% | 62.05% |
| No. of Shareholders | 79,862 | 97,053 | 1,37,506 | 1,37,193 | 1,52,046 | 1,56,398 | 1,60,561 | 1,51,206 | 2,05,266 | 1,94,777 | 1,94,559 | 1,88,986 |
Fundamentals
Market Cap₹ 1,099 Cr.
Current Price₹ 28.8
Stock P/E48.9
Book Value₹ 13.6
ROCE6.14 %
ROE5.78 %
Dividend Yield0.35 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)-10%
Compounded Profit Growth (TTM)-71%
Consolidated figures.
Valuation
Market capRs 1,083 Cr
Enterprise valueRs 1,153 Cr
P/E (TTM)42.70x
Price to book1.80x
Price to sales2.30x
EV / EBITDA21.25x
EV / EBIT31.18x
EV / sales2.45x
Price to cash flow40.21x
Earnings yield2.34%
Dividend yield0.35%
P/E, 3-year average25.65x
P/B, 3-year average2.25x
P/E, 5-year average17.84x
P/B, 5-year average1.78x
Profitability
Operating margin (excl. other income)20.48%
Operating margin (incl. other income)24.68%
EBITDA margin11.52%
Pre-tax margin4.97%
Net profit margin5.39%
Net margin, latest quarter5.57%
ROE13.50%
ROCE15.82%
ROA9.03%
ROE, 3-year average14.94%
ROCE, 3-year average17.44%
ROA, 3-year average9.87%
ROE, 5-year average23.22%
ROCE, 5-year average23.62%
ROA, 5-year average15.94%
ROIC (approx.)4.21%
Tax rate23.68%
Other income / net worth3.42%
Growth
Sales growth (latest year)22.38%
Profit growth (latest year)21.65%
Sales CAGR, 3 years24.95%
Sales CAGR, 5 years28.55%
Profit CAGR, 3 years20.21%
Profit CAGR, 5 years27.90%
Sales growth QoQ-0.52%
Profit growth QoQ-12.32%
Sales growth YoY (latest quarter)-5.44%
Per share
EPS (TTM)Rs 0.66
EPS (latest year)Rs 1.82
EPS (latest quarter)Rs 0.18
EPS, 3-year averageRs 1.78
EPS, 5-year averageRs 13.99
Book value per shareRs 15.72
Sales per shareRs 12.32
Cash flow per shareRs 0.70
Free cash flow per shareRs -0.97
Dividend per share (latest year)Rs 0.10
Dividend per share, 3-year averageRs 0.40
Dividend per share, 5-year averageRs 0.55
Dividends
Dividend payout5.49%
Dividend payout, 3-year average5.61%
Dividend payout, 5-year average6.30%
Efficiency
Asset turnover0.58x
Fixed asset turnover1.32x
Inventory turnover2.57x
Inventory days142 days
Debtor days137 days
Debtors turnover2.66x
Creditor days87 days
Cash conversion cycle193 days
Working capital days71 days
Leverage
Total debtRs 142 Cr
Cash and bankRs 72 Cr
Net debtRs 70 Cr
Debt to equity0.24x
Net debt / EBITDA1.30x
Interest coverage2.72x
Current ratio (filing 2026-03-31)1.44x
Quick ratio (filing 2026-03-31)1.17x
Trade payables (filing 2026-03-31)Rs 59 Cr
Owners' fund to total sources71.00%
Debt to assets16.82%
Cash flow
Cash from Operating Activity (latest year)Rs 27 Cr
Cash from Investing Activity (latest year)Rs -93 Cr
Cash from Financing Activity (latest year)Rs 81 Cr
Net Cash Flow (latest year)Rs 15 Cr
Free cash flow (latest year)Rs -37 Cr
FCFE (approx.: FCF + change in debt)Rs -46 Cr
Cash from ops / profit, 5 years0.25x
Sales to cash flow18.13x
Statement figures
Net sales (TTM)Rs 471 Cr
Net sales (latest year)Rs 488 Cr
Sales (latest quarter)Rs 121 Cr
Operating profit excl. other income (latest year)Rs 100 Cr
Operating profit (latest quarter)Rs 17 Cr
Other income (TTM)Rs 8 Cr
EBITDA (TTM)Rs 54 Cr
PBDT (TTM)Rs 41 Cr
Profit before tax (TTM)Rs 23 Cr
Tax (latest year)Rs 22 Cr
Net profit (TTM)Rs 25 Cr
Net profit (latest year)Rs 70 Cr
Net profit (latest quarter)Rs 7 Cr
Depreciation (TTM)Rs 17 Cr
Depreciation (latest quarter)Rs 4 Cr
Interest (TTM)Rs 14 Cr
Cost of goods sold (latest year)Rs 243 Cr
Total expenditure (latest year)Rs 388 Cr
Total income (latest year)Rs 509 Cr
Share capitalRs 38 Cr
ReservesRs 563 Cr
Shareholders' fundsRs 601 Cr
Total assetsRs 846 Cr
Net blockRs 370 Cr
Capital work in progressRs 9 Cr
InvestmentsRs 0 Cr
ReceivablesRs 184 Cr
InventoryRs 94 Cr
Other liabilitiesRs 103 Cr
Shares outstanding (crore)38.21
Ownership
Promoter holding36.69% (-7.45 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 42.7 is at the 48th percentile of its own 4.0-year range
(median 42.7, low 18.9, high 79.5).
P/B 1.80 is at the 7th percentile (median 8.81).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | SIGACHI | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -6.5% | -2.8% | -3.7 pts |
| 1 month | -10.7% | -6.8% | -3.9 pts |
| 3 months | +24.8% | -7.6% | +32.5 pts |
| 6 months | +67.5% | +0.4% | +67.1 pts |
| 1 year | -27.3% | -9.9% | -17.4 pts |
| 2 years | -52.0% | -13.6% | -38.5 pts |
| 3 years | -29.2% | +14.2% | -43.4 pts |
1 mutual fund schemes hold about ₹0 Cr.
Over three months 0 bought more and 0 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Bandhan BSE Healthcare Index Fund | 0.05% | 0 |
Red flags
F-score 5 of 8| explain | Weak cash conversion Cash from operations was 27% of net profit over the last 3 years |
| look | Share dilution Share count up 16% in a year |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹121 Cr -5.4% vs Jun 2025.
Net profit ₹8 Cr +108.1%.
Against our estimate for Jun 2026: sales +5.6%, profit +126.4% in line. Our estimate for Sep 2026: sales Rs 105 Cr, profit Rs 7 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-09-22 | Dividend - Re 0.10 Per Share | |
| 2025-09-16 | Dividend - Rs 0.10 Per Share | |
| 2024-08-28 | Annual General Meeting/Dividend - Re 0.10 Per Share | |
| 2023-10-09 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Re 1/- Per Share | 0.1000 |
| 2023-08-31 | Annual General Meeting/Dividend - Re 1 Per Share | |
| 2022-08-19 | Annual General Meeting | |
| 2022-08-02 | Interim Dividend - Re 1 Per Share |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
High low price variation greater than 100perc in previous 6 monthsHigh low price variation greater than 75perc in previous 3 months
Quick answers
What is the market cap of Sigachi Industries Ltd?
Sigachi Industries Ltd (SIGACHI) has a market capitalisation of Rs 1,099 Cr. at the 2026-10-01 close.
What is the P/E ratio of Sigachi Industries Ltd?
Sigachi Industries Ltd trades at a P/E of 48.9 on trailing twelve-month profit, at the 2026-10-01 close.
What were Sigachi Industries Ltd's latest quarterly results?
In the Jun 2026 quarter, Sigachi Industries Ltd sales was Rs 121 Cr (-5.4% vs Jun 2025) and net profit was Rs 8 Cr.
What is the 52-week high and low of Sigachi Industries Ltd?
The 52-week high is Rs 40.85 and the 52-week low is Rs 16.65.